CYRAMZA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0002-7669 -
Package NDC
0002-7669-01 -
Application number
BLA125477 -
SPL ID
161cb5e7-7955-45e5-bdde-9be94fdbe76a -
SPL set ID
c6080942-dee6-423e-b688-1272c2ae90d4 -
UNII
D99YVK4L0X -
RxCUI
1657775 -
RxCUI
1657777 -
RxCUI
1657780 -
RxCUI
1657781
What the source publishes
- Labeler
- Eli Lilly and Company
- Active ingredients
- ramucirumab
- Form
- SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "CYRAMZA",
"splId": "161cb5e7-7955-45e5-bdde-9be94fdbe76a",
"labels": [
{
"setId": "c6080942-dee6-423e-b688-1272c2ae90d4",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c6080942-dee6-423e-b688-1272c2ae90d4",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c6080942-dee6-423e-b688-1272c2ae90d4"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Eli Lilly and Company",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7669-01) / 10 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "0002-7669-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20140421"
}
],
"productId": "0002-7669_161cb5e7-7955-45e5-bdde-9be94fdbe76a",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "0002-7669",
"deaSchedule": null,
"genericName": "ramucirumab",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RAMUCIRUMAB",
"strength": "10 mg/mL"
}
],
"applicationNumber": "BLA125477",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140421",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000191009",
"N0000020032"
],
"unii": [
"D99YVK4L0X"
],
"rxcui": [
"1657775",
"1657777",
"1657780",
"1657781"
],
"spl_set_id": [
"c6080942-dee6-423e-b688-1272c2ae90d4"
],
"pharm_class_epc": [
"Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]"
],
"pharm_class_moa": [
"VEGFR2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Eli Lilly and Company"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0002-7669_161cb5e7-7955-45e5-bdde-9be94fdbe76a"